Quidel (QDEL) Hits New 52-Week High and Low at $66.39

Quidel Co. (NASDAQ:QDEL) hit a new 52-week high and low during trading on Tuesday . The stock traded as low as $66.39 and last traded at $66.07, with a volume of 16094 shares changing hands. The stock had previously closed at $64.73.

QDEL has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Quidel from a “sell” rating to a “hold” rating in a research note on Friday, February 23rd. UBS Group upgraded shares of Quidel from an “outperform” rating to a “strong-buy” rating in a research note on Thursday, March 8th. Raymond James upgraded shares of Quidel from an “outperform” rating to a “strong-buy” rating and reduced their target price for the company from $55.00 to $47.00 in a research note on Thursday, March 8th. BidaskClub raised Quidel from a “hold” rating to a “buy” rating in a report on Saturday, March 10th. Finally, Craig Hallum initiated coverage on Quidel in a report on Monday, March 26th. They issued a “buy” rating and a $62.00 price target for the company. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and four have issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $59.29.

The company has a quick ratio of 1.06, a current ratio of 1.36 and a debt-to-equity ratio of 0.40. The firm has a market cap of $2.42 billion, a PE ratio of -935.86, a PEG ratio of 1.12 and a beta of 0.91.



Quidel (NASDAQ:QDEL) last released its quarterly earnings results on Tuesday, May 8th. The company reported $1.29 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.28. Quidel had a return on equity of 12.54% and a net margin of 3.08%. The business had revenue of $169.10 million during the quarter, compared to analysts’ expectations of $151.50 million. During the same period in the previous year, the business posted $0.45 earnings per share. The firm’s revenue for the quarter was up 129.4% compared to the same quarter last year. equities analysts predict that Quidel Co. will post 2.3 EPS for the current fiscal year.

In other Quidel news, CEO Douglas C. Bryant sold 36,000 shares of the business’s stock in a transaction dated Monday, April 30th. The stock was sold at an average price of $56.09, for a total transaction of $2,019,240.00. Following the completion of the sale, the chief executive officer now directly owns 306,313 shares of the company’s stock, valued at approximately $17,181,096.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Douglas C. Bryant sold 12,000 shares of the business’s stock in a transaction dated Tuesday, March 27th. The stock was sold at an average price of $51.51, for a total value of $618,120.00. Following the sale, the chief executive officer now directly owns 306,313 shares of the company’s stock, valued at $15,778,182.63. The disclosure for this sale can be found here. Insiders have sold a total of 201,006 shares of company stock valued at $11,728,499 over the last three months. Company insiders own 16.70% of the company’s stock.

A number of large investors have recently made changes to their positions in the business. BlackRock Inc. raised its holdings in Quidel by 2.1% during the 4th quarter. BlackRock Inc. now owns 1,790,347 shares of the company’s stock worth $77,611,000 after purchasing an additional 36,236 shares during the last quarter. Macquarie Group Ltd. raised its holdings in Quidel by 12.7% during the 4th quarter. Macquarie Group Ltd. now owns 1,132,743 shares of the company’s stock worth $49,105,000 after purchasing an additional 128,081 shares during the last quarter. Millennium Management LLC raised its holdings in Quidel by 72.0% during the 1st quarter. Millennium Management LLC now owns 996,815 shares of the company’s stock worth $51,645,000 after purchasing an additional 417,106 shares during the last quarter. Fred Alger Management Inc. raised its holdings in Quidel by 7.3% during the 4th quarter. Fred Alger Management Inc. now owns 985,376 shares of the company’s stock worth $42,716,000 after purchasing an additional 66,926 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Quidel by 9.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 925,055 shares of the company’s stock worth $47,927,000 after purchasing an additional 76,339 shares during the last quarter. 90.15% of the stock is owned by hedge funds and other institutional investors.

Quidel Company Profile

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus products point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye.

Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply